Correlation Between Achilles Therapeutics and Comera Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Comera Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Comera Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Comera Life Sciences, you can compare the effects of market volatilities on Achilles Therapeutics and Comera Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Comera Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Comera Life.

Diversification Opportunities for Achilles Therapeutics and Comera Life

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Achilles and Comera is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Comera Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Comera Life Sciences and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Comera Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Comera Life Sciences has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Comera Life go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Comera Life

Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.59 times more return on investment than Comera Life. However, Achilles Therapeutics PLC is 1.69 times less risky than Comera Life. It trades about 0.02 of its potential returns per unit of risk. Comera Life Sciences is currently generating about -0.1 per unit of risk. If you would invest  113.00  in Achilles Therapeutics PLC on August 31, 2024 and sell it today you would lose (5.00) from holding Achilles Therapeutics PLC or give up 4.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy28.45%
ValuesDaily Returns

Achilles Therapeutics PLC  vs.  Comera Life Sciences

 Performance 
       Timeline  
Achilles Therapeutics PLC 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Comera Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Comera Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Comera Life is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Achilles Therapeutics and Comera Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Achilles Therapeutics and Comera Life

The main advantage of trading using opposite Achilles Therapeutics and Comera Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Comera Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Comera Life will offset losses from the drop in Comera Life's long position.
The idea behind Achilles Therapeutics PLC and Comera Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities